Full-Time

Director/Sr. Director

Regulatory Affairs-CMC

Confirmed live in the last 24 hours

Scorpion Therapeutics

Scorpion Therapeutics

51-200 employees

Develops precision oncology treatments for cancer

Biotechnology
Healthcare

Compensation Overview

$225k - $240kAnnually

+ Annual Target Bonus + Equity Ownership

Expert

Boston, MA, USA

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • Advanced degree (Ph.D., Pharm.D., or equivalent) in a relevant scientific discipline (e.g., Chemistry, Pharmacy, Chemical Engineering).
  • Minimum of 10 years of experience in global regulatory affairs, with a focus on CMC, in the pharmaceutical or biotechnology industry. Experience in solid dosage form with oncology products is highly desirable.
  • In-depth knowledge of global CMC regulatory requirements and guidelines (FDA, EMA, ICH, etc.). Proven track record of successful CMC submissions for INDs, NDAs, BLAs, and other regulatory filings.
  • Demonstrated ability to lead and develop high-performing teams. Strong strategic thinking, decision-making, and problem-solving skills.
  • Excellent written and verbal communication skills. Ability to effectively communicate complex technical information to regulatory authorities, senior management, and cross-functional teams.
  • Strong project management skills, with the ability to manage multiple projects simultaneously and meet deadlines.
  • Ability to thrive in a fast-paced, dynamic environment and manage changing priorities.
Responsibilities
  • Lead the development of global regulatory CMC strategies for solid dosage forms, ensuring alignment with overall product development plans and company goals.
  • Oversee the preparation, review, and submission of high-quality CMC sections of regulatory filings, including INDs, NDAs, BLAs, and other global regulatory submissions including query responses. Ensure all documentation meets regulatory standards and is submitted within timelines.
  • Ensure CMC activities comply with relevant regulatory guidelines (FDA, EMA, ICH, etc.). Identify potential regulatory risks related to CMC and develop strategies to mitigate these risks.
  • Serve as the primary CMC regulatory contact with regulatory authorities. Maintain effective communication with internal and external stakeholders to ensure alignment and understanding of CMC regulatory strategies and requirements including change control.
  • Lead and mentor a team of regulatory professionals, fostering a collaborative and high-performance work environment. Provide strategic direction and professional development support to team members.
  • Collaborate with R&D, Quality, Manufacturing, and other departments to ensure CMC regulatory strategies are integrated into overall product development plans. Provide regulatory guidance and support to cross-functional teams throughout the product lifecycle.
  • Monitor and interpret evolving regulatory guidelines and trends, ensuring the company's CMC strategies remain current and compliant with global standards. Provide regulatory insights and recommendations to senior leadership.
  • Lead CMC regulatory projects, ensuring all deliverables are met on time and within scope. Manage relationships with external partners and vendors involved in regulatory CMC activities.
Scorpion Therapeutics

Scorpion Therapeutics

View

Scorpion Therapeutics develops precision oncology treatments aimed at targeting specific cancer drivers. Their approach involves creating drugs that interact with validated cancer targets, enhancing their selectivity and safety to improve treatment efficacy. Unlike many competitors, Scorpion Therapeutics focuses on forming partnerships with larger pharmaceutical companies for the distribution of their drugs, allowing them to concentrate on research and development. Their goal is to provide effective cancer treatments that can be rapidly deployed to healthcare providers and patients worldwide.

Company Stage

Series C

Total Funding

$408.5M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Raised $150M in Series C funding, strengthening their oncology pipeline and financial position.
  • Partnership with Pierre Fabre enhances distribution and sales capabilities in Europe and China.
  • Growing demand for CNS-penetrant therapies aligns with Scorpion's focus on innovative cancer treatments.

What critics are saying

  • Recent leadership changes may disrupt strategic direction and operational continuity.
  • Reliance on partnerships for revenue exposes Scorpion to financial risks if expectations aren't met.
  • Intensifying competition in precision oncology could impact Scorpion's market share and pricing power.

What makes Scorpion Therapeutics unique

  • Scorpion Therapeutics specializes in precision medicine for cancer, focusing on small-molecule drugs.
  • Their Precision Oncology 2.0 strategy aims to redefine cancer treatment with innovative approaches.
  • Scorpion's STX-478 and STX-721 show potential best-in-class profiles for specific cancer mutations.

Help us improve and share your feedback! Did you find this helpful?